EnlivenHealth Celebrates American Pharmacists Month » Learn More

EnlivenHealth Weekly Recap | May 17th, 2025

Here are the top stories from the last week:

Industry Updates

Walgreens Expanding Use of Robots Filling Prescriptions
Walgreens is expanding its use of robots in micro-fulfillment centers to fill prescriptions, aiming to serve over 5,000 stores by year-end. This move is intended to free up pharmacists for more patient care activities. Read article »

Medication Meltdown: Unpacking Drug Shortages
Drug shortages disrupt patient care, increase medication errors, and impose financial burdens on healthcare systems. Read article »

Behind Closed Doors, What Happens When Pharmacies Close?
Learn about the widespread closures of grocery store and independent pharmacies across the United States, as well as the reasons behind these closures. Read article »

House Energy and Commerce Passes Health Section of Budget
The House Committee on Energy and Commerce passed a budget reconciliation bill that includes provisions to eliminate spread pricing and require transparent reimbursement in state Medicaid managed care programs, which could impact pharmacy operations. Read article »

Drug, Technology & Treatment Updates

IQVIA Institute Releases Understanding the Use of Medicines in the U.S. 2025 Report
The report highlights trends in medicine use, including increased spending on novel therapies and the impact of evolving care standards on patient access and costs. Read article »

Aurobindo’s Eugia Pharma Specialities Obtains FDA OK for Generic Sprycel
Aurobindo’s subsidiary, Eugia Pharma Specialities, received FDA approval to manufacture and market dasatinib tablets, a generic version of Sprycel, used to treat certain types of leukemia. The product is expected to launch in Q1 FY26. Read article »

Lupin Intros Generic Jynarque
Lupin has launched tolvaptan tablets, a generic version of Jynarque, in the U.S. The medication is used to slow kidney function decline in adults with autosomal dominant polycystic kidney disease. Read article »

Teva, Alvotech Receive FDA Nod for Interchangeability of Selardsdi with Stelara
The FDA has approved Selarsdi as interchangeable with Stelara for treating conditions like plaque psoriasis and psoriatic arthritis, enhancing access to affordable treatment options. Read article »

Lupin Launches Generic Aptiom
Lupin has introduced eslicarbazepine acetate tablets, a generic version of Aptiom, for treating partial-onset seizures in patients aged 4 and older. Read article »

FDA Grants Orphan Drug Designation to Oligonucleotide Therapeutic for Spinocerebellar Ataxia
Cure Rare Disease’s CRD-002 receives FDA orphan drug designation, advancing hope for SCA3 treatment with innovative oligonucleotide therapy. Read article »

FDA Approves Brekiya for Acute Treatment of Migraine, Cluster Headaches
The approved injection contains dihydroergotamine (DHE), which is the same medication used in hospitals, in a ready-to-use device. Read article »

Camber Launches Temozolomide Capsules, USP
This article announces the launch of Temozolomide Capsules, USP by Camber, which is an alkylating drug used in treatment. Read article »

Camber Launches Eltrombopag Tablets and Oral Suspension
Camber has launched eltrombopag tablets and oral suspension, with a copayment program allowing eligible patients to pay as little as $0 out-of-pocket. Read article »

X

Amplicare is now part of EnlivenHealth®

X

FDSRX is now part of EnlivenHealth®